Search

everythinglearnresearchcommunity

for

Search:↓

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Treating hidradenitis suppurativa needs long-term care and teamwork among doctors, but there's a lack of strong guidance on how to do it.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Minoxidil and spironolactone slow hair loss in women.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

The combination treatment showed a higher response rate but no significant survival benefits.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.